Method for producing recombinant virus

Details for Australian Patent Application No. 2011215201 (hide)

Owner Otsuka Pharmaceutical Co., Ltd.

Inventors Kawasaki, Masanori; Inagaki, Katsuya; Mizukoshi, Masami

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011215201

PCT Pub. Number WO2011/099541

Priority 12/705,317 12.02.10 US

Filing date 10 February 2011

Wipo publication date 18 August 2011

International Classifications

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/117 Mutation or genetic engineering - Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs

Event Publications

16 August 2012 PCT application entered the National Phase

  PCT publication WO2011/099541 Priority application(s): WO2011/099541

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011215208-Protein synthesis promoter

2011215191-Mobile terminal device and uplink control information signal transmission method